Dutch Cancer Foundation (KWF) grant for Dömling
Prof. Alex Dömling, Drug Design group of GRIP, together with co-workers of the UMCG (Profs. H. Nijmans and P. Elsinga) recently was awarded a grant of approx. €840.000 by the Dutch Cancer Foundation (KWF) research and implementation programme. The project is titled: Non-invasive whole-body imaging of immune checkpoints using radiolabeled small molecules as predictive biomarker for response to therapy.
In the project, small molecules will be developed for use as PET tracers and provide proof-of-concept for their use as a predictive biomarker. The multidisciplinary team of clinicians, chemists, nuclear medicine specialists and preclinical research staff involved in this project makes us uniquely suited to develop an imaging product with near-future clinical applications.
Last modified: | 08 June 2017 1.25 p.m. |
More news
-
14 July 2025
ERC Proof of Concept grant for Kottapalli and Covi
Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).
-
10 July 2025
Dutch Research Agenda funding for nanomedicine research
Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.
-
10 July 2025
Dutch research Agenda funding for circular bio-based materials
Prof Anastasiia Krushynska has been granted a EUR 600,000 National Science Agenda (NWA) funding to help develop innovative technologies for converting low-grade organic waste into durable, recyclable materials.